Carmot Therapeutics Appoints Michael Gray as Chief Financial Officer and Chief Operating Officer

3 years ago

Gray brings significant biotech financial and operations experience to Carmot to advance a clinical pipeline of therapies to treat people…

Eloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement

3 years ago

Company continuing to prepare for advancement of clinical assets, including ELX-02 pivotal study in Alport Syndrome and ZKN-013 Phase 1…

ABVC BioPharma Announces Collaboration With MerDury BioPharma for New Product Development and Commercialization

3 years ago

FREMONT, CA, June 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (“ABVC” or the “Company”) (NASDAQ: ABVC),…

COMPASS Pathways’ key patents upheld by the US Patent and Trademark Office

3 years ago

PTAB rejects two requests for rehearing of the USPTO's decision denying institution of post-grant review (PGR) of U.S. patent numbers…

Alignment Health Appoints 3 New Executives to Further Drive Strategic Growth Nationally

3 years ago

Todd Macaluso, David Milligan and Joe Kanatzar will be responsible for expanding premier care access for seniors throughout the US…

Enlivex to Present at the 2023 Jefferies Healthcare Conference

3 years ago

Nes-Ziona, Israel, June 06, 2023 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage macrophage reprogramming immunotherapy company, today…

Healthmap Solutions Names Eli Wahesh as Chief Operating Officer

3 years ago

Leadership Expansion Part of Healthmap’s Strategic Growth InitiativeTAMPA, Fla., June 06, 2023 (GLOBE NEWSWIRE) -- Kidney population health management company…

Madrigal Pharmaceuticals Supports International NASH Day on June 8

3 years ago

Company expands support for NASH disease education through patient advocacy partnerships and a new digital campaign for patients with at-risk…

Editas Medicine to Host Virtual Event to Discuss EDIT-301 Clinical Data from the RUBY Trial for Severe Sickle Cell Disease and the EDITHAL Trial for Transfusion-dependent Beta Thalassemia

3 years ago

CAMBRIDGE, Mass., June 06, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that…

Be The Match® Celebrates One Thousand “Get in the Game” Life-Saving Donors!

3 years ago

Partnership between Be The Match and the Andy Talley Bone Marrow Foundation that engages student athletes and coaches has added…